Moreover, platelet-derived TGF-β was shown to activate TGF-β/Smad and NF-κ B pathways in tumor cells, thereby initiating and/or stabilizing their transition into an invasive mesenchymal-like phenotype [46]. The gene discussed is TGFB1; the disease is neoplasm.